Acromegaly Epidemiology Forecast till 2030

Acromegaly Epidemiology Forecast

DelveInsight’sAcromegaly Epidemiology Forecast–2030report delivers an in-depth understanding of the Acromegaly, historical and forecasted epidemiology as well as the Acromegaly trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan.

Acromegaly is a rare and chronic disorder characterized by excess growth hormone secretion and elevated insulin-like growth factor-1 levels, most often caused by a pituitary Adenoma.

Acromegaly Epidemiology Insights

  • The total prevalent cases of Acromegaly in 2017- 64,508
  • The diagnosed patient pool cases in 2017 – 49,814
  • The prevalent population of Acromegaly in the United States in 2017 – 28,671

    The diagnosed cases of Acromegaly based on types of Adenomas in the US in 2017:

  • 18,349 – Macroadenomas
  • 4,587 – Microadenomas
    The prevalent cases of Acromegaly in Japan in 2017 – 10,690
  • EU5 countries occupied around 38.98% of the patient pool amongst 7MM in 2017

Acromegaly Epidemiology Segmentation in 7MM from 2017 to 2030

  • Total Prevalent Cases of Acromegaly
  • Diagnosed Cases of Acromegaly
  • Origin Specific Diagnosed Prevalent Cases of Acromegaly
  • Diagnosed Cases of Acromegaly Based on Types of Adenomas

Scope of the Report

  • The report covers the descriptive overview of Acromegaly, explaining its etiology, signs and symptoms, pathophysiology, genetic basis, and currently available therapies.
  • The report provides insight into the 7MM historical and forecasted patient pool covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom) and Japan.
  • The report assesses the disease risk and burden and highlights the unmet needs of Acromegaly.
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population.
  • The report provides the segmentation of the disease epidemiology for 7MM by Total Prevalent Cases of Acromegaly, Total Diagnosed Prevalent Cases of Acromegaly, Origin Specific Cases of Acromegaly, and Diagnosed Cases of Acromegaly Based on Type of Adenomas.

Request for sample pages
Table of contents

1. Key Insights

2. Executive Summary

3. Acromegaly Epidemiology Overview at a Glance

3.1. Epidemiology (%) Distribution of Acromegaly in 2017

3.2. Epidemiology (%) Distribution of Acromegaly in 2030

4. Acromegaly (ACM): Disease Overview

4.1. Introduction

4.2. Signs and Symptoms

4.3. Classification of Pituitary Adenomas

4.4. Clinical Manifestations of Acromegaly

4.5. Etiology

4.6. Pathophysiology

4.7. Genetic Bases of Acromegaly

4.8. Pathogenesis

4.9. Diagnosis

4.9.1. Diagnosis Guidelines

4.9.2. Endocrine Society Clinical Practice Guideline-United Kingdom

4.9.3. American Association of Clinical Endocrinologists (AACE) – USA

5. Epidemiology and Patient Population

5.1. Key Findings

5.2. Methodology

5.3. Total Prevalent Cases of Acromegaly in the 7MM

5.4. Total Diagnosed Cases of Acromegaly in the 7MM

6. United States Epidemiology

6.1. Total Prevalent Cases of Acromegaly in the United States

6.2. Diagnosed Cases of Acromegaly in the United States

6.3. Origin Specific Diagnosed Prevalent Cases of Acromegaly in the United States

6.4. Diagnosed Cases of Acromegaly Based on Types of Adenomas in the US

7. EU5 Epidemiology

7.1. Germany

7.1.1. Total Prevalent Cases of Acromegaly in Germany

7.1.2. Diagnosed Cases of Acromegaly in Germany

7.1.3. Origin Specific Diagnosed Prevalent Cases of Acromegaly in Germany

7.1.4. Diagnosed Cases of Acromegaly Based on Type of Adenomas in Germany

7.2. France

7.2.1. Total Prevalent Cases of Acromegaly in France

7.2.2. Diagnosed Cases of Acromegaly in France

7.2.3. Origin Specific Diagnosed Prevalent Cases of Acromegaly in France

7.2.4. Diagnosed Cases of Acromegaly Based on Type of Adenomas in France

7.3. Italy

7.3.1. Total Prevalent Cases of Acromegaly in Italy

7.3.2. Diagnosed Cases of Acromegaly in Italy

7.3.3. Origin Specific Diagnosed Prevalent Cases of Acromegaly in Italy

7.3.4. Diagnosed Cases of Acromegaly Based on Type of Adenomas in Italy

7.4. Spain

7.4.1. Total Prevalent Cases of Acromegaly in Spain

7.4.2. Diagnosed Cases of Acromegaly in Spain

7.4.3. Origin Specific Diagnosed Prevalent Cases of Acromegaly in Spain

7.4.4. Diagnosed Cases of Acromegaly Based on Type of Adenomas in Spain

7.5. United Kingdom

7.5.1. Total Prevalent Cases of Acromegaly in the United Kingdom

7.5.2. Diagnosed Cases of Acromegaly in the United Kingdom

7.5.3. Origin Specific Diagnosed Prevalent Cases of Acromegaly in the United Kingdom

7.5.4. Diagnosed Cases of Acromegaly Based on Type of Adenomas in the United Kingdom

8. Japan Epidemiology

8.1. Total Prevalent Cases of Acromegaly in Japan

8.2. Diagnosed Cases of Acromegaly in Japan

8.3. Origin-Based Diagnosed Prevalent Cases of Acromegaly in Japan

8.4. Diagnosed Cases of Acromegaly Based on Types of Adenomas in Japan

9. Appendix

9.1. Report Methodology

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight